Pfizer to pay $60 million to settle claims that Biohaven paid kickbacks to doctors
The alleged violations occurred before Pfizer bought Biohaven and its migraine treatment three years ago for $11.6 billion.
Pfizer to pay nearly $60M over kickbacks for migraine drug once promoted by Lady Gaga
The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so that physicians would prescribe a specific migraine drug to patients.
Pfizer Pays Nearly $60 Million To Resolve False Claims Allegations
The DOJ announces Pfizer agreed to pay nearly $60 million to resolve false claims allegations. The SEC creates a task force dedicated to the development of a clear and comprehensive regulatory framework for crypto assets.
Pfizer to Pay $60 Million in Kickback, False Claims Settlement
Pfizer will pay $60 million to settle allegations that one of its subsidiaries incentivized healthcare providers to prescribe one of its drugs, resulting in the submission of false claims to federal healthcare programs.
Pfizer settles Biohaven kickback case with DOJ for $60M
Pfizer (PFE) has agreed to pay nearly $60M to resolve allegations that its Biohaven unit paid kickbacks to induce prescriptions for its migraine drug Nurtec ODT. Read more here.
Pfizer Settles $59.7M Medicare Kickback Case Over Biohaven Practices
Pfizer (NYSE:PFE) has agreed to pay $59.7 million to resolve allegations that Biohaven Pharmaceuticals, acquired by Pfizer in October 2022, defrauded Medicare and other healthcare programs by offering kickbacks to
Pfizer to pay $59.7 million over kickbacks for migraine drug
Pfizer will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs by paying kickbacks so doctors would prescribe the migraine drug Nurtec ODT,
Biohaven Ltd. (NYSE:BHVN) Receives $63.00 Average Price Target from Analysts
Shares of Biohaven Ltd. (NYSE:BHVN – Get Free Report) have been assigned a consensus rating of “Buy” from the fourteen analysts that are presently covering the company, MarketBeat.com reports.
Hosted on MSN26d
Biohaven Stock Surges After Director Acquires Shares Worth Over $1M: Retail Sentiment Turns Bullish
Shares of Biohaven (BHVN) gained in morning trade on Tuesday after the company’s director John W. Childs acquired shares worth $1.04 million on Monday. According to Biohaven’s U.S. Securities ...
Biohaven enters multi-target collaboration with Merus
Biohaven (BHVN) announced a multi-target collaboration with Merus (MRUS). This collaboration will co-develop three programs encompassing highly ...
bovnews8d
Biohaven Ltd (BHVN) Stock: Surpassing Expectations in the Market?
Jefferies has recently initiated Biohaven Ltd (BHVN) stock to Buy rating, as announced on September 16, 2024, according to Finviz. Earlier, on September 4, 2024, Bernstein had initiated the stock to ...
sandiegocountynews8h
Pfizer to pay $60M over alleged improper physician payments
Pharmaceutical company Pfizer Incorporated on behalf of its wholly-owned subsidiary Biohaven Pharmaceutical Holding Company Ltd., has agreed ...